Brand Intelligence Graphcompany
Company Overview
About AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Business Model & Competitive Advantage
The company has successfully navigated the Humira patent cliff that began in 2023, when biosimilar competitors entered the US market after years of exclusivity. AbbVie's strategy to offset Humira erosion centered on Skyrizi (risankizumab, for psoriasis and Crohn's disease) and Rinvoq (upadacitinib, for rheumatoid arthritis and other immune conditions), both of which have grown rapidly to partially offset Humira's revenue decline. Revenue in 2024 was approximately $55 billion.
Competitive Landscape 2025–2026
In 2025, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics to bolster its neuroscience pipeline with treatments for schizophrenia and Parkinson's disease. The company also acquired Aliada Therapeutics (Alzheimer's focused) for $1.4 billion. AbbVie's aesthetics franchise (Botox via Allergan acquisition, Juvederm) remains a significant revenue contributor. The company's 2025-2026 strategic priorities include advancing its neuroscience and oncology pipeline, executing the Allergan integration fully, and managing pricing pressures from the Inflation Reduction Act's drug negotiation provisions.
Recent Activity
View all →Key Differentiators
Market Leader
AbbVie is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
S2
S2 is an AI-powered security platform focused on vulnerability discovery and attack surface management for enterprise security teams. The company's platform combines automated scanning, AI-powered ana
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Zocdoc
Zocdoc operates a two-sided marketplace connecting patients with physicians, dentists, and mental health providers who accept their specific insurance and have real-time appointment availability. Pati
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare AbbVie with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from AbbVie? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim AbbVie Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention AbbVie vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →